Generation of recombinant pandemic H1N1 influenza virus with the HA cleavable by bromelain and identification of the residues influencing HA bromelain cleavage
- 20 January 2012
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 30 (5), 872-878
- https://doi.org/10.1016/j.vaccine.2011.11.101
Abstract
No abstract availableKeywords
Funding Information
- HHS
- ASPR
- BARDA
This publication has 36 references indexed in Scilit:
- Comparison of a Live Attenuated 2009 H1N1 Vaccine with Seasonal Influenza Vaccines against 2009 Pandemic H1N1 Virus Infection in Mice and FerretsThe Journal of Infectious Diseases, 2011
- Generation of Live Attenuated Novel Influenza Virus A/California/7/09 (H1N1) Vaccines with High Yield in Embryonated Chicken EggsJournal of Virology, 2010
- Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza VirusNew England Journal of Medicine, 2009
- Emergence and pandemic potential of swine-origin H1N1 influenza virusNature, 2009
- Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemicNature, 2009
- Influenza Pandemics of the 20th CenturyEmerging Infectious Diseases, 2006
- Influenza: lessons from past pandemics, warnings from current incidentsNature Reviews Microbiology, 2005
- Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (flumist) derived from cold-adapted a/ann arbor/6/60Virology, 2003
- Mortality Associated With Influenza and Respiratory Syncytial Virus in the United StatesJAMA, 2003
- Principles Underlying the Development and Use of Live Attenuated Cold-Adapted Influenza A and B Virus VaccinesViral Immunology, 2002